Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators

被引:3
|
作者
Miwa, Naoyuki [1 ]
Nagata, Yasutoshi [1 ]
Yamaguchi, Tetsuo [1 ]
Nagase, Masashi [1 ]
Sasaki, Takeshi [2 ]
Nozato, Toshihiro [1 ]
Ashikaga, Takashi [1 ]
Goya, Masahiko [3 ]
Hirao, Kenzo [4 ]
机构
[1] Japanese Red Cross Musashino Hosp, Dept Cardiol, 1-26-1 Kyonancho, Tokyo 1808610, Japan
[2] Disaster Med Ctr, Dept Cardiovasc Med, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Dept Cardiovasc Med, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan
关键词
Brugada syndrome; Defibrillator screening; Holler monitoring; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; BRUGADA SYNDROME; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; ELECTROCARDIOGRAM; ARRHYTHMIAS; PREVALENCE; CANDIDACY; EFFICACY; PATTERN; SAFETY;
D O I
10.1016/j.hrthm.2019.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are an established therapy for preventing sudden cardiac death. However, a considerable number of patients still undergo inappropriate shocks even after conventional preim-plantation electrocardiographic (ECG) screening. OBJECTIVE This study aimed to elucidate the additional effect of diurnal variations in the QRS complex and T waves of 24-hour Hotter screening on S-ICD eligibility. METHODS Patients with transvenous ICDs who did not need pacing were selected for the study. The ECG was recorded by placing the electrodes to simulate the 3 sensing vectors of the S-ICD, with the patient in the standing and supine positions (conventional), during exercise, and during 24-hour Hotter screening. We investigated the additional discrimination of diurnal variations in patients ineligible for S-ICDs as well as characteristics of those patients. RESULTS Of the 86 patients (82% men; mean age 54 +/- 16 years) analyzed by all 3 screenings, 2 (2.3%) and 3 (3.4%) were considered ineligible by conventional and exercise screening, respectively. An additional 21 patients (24.4%) were found ineligible through Holler screening. A multivariate logistic regression analysis demonstrated that Brugada syndrome and an increased QRS duration per millisecond were associated with ineligibility (odds ratio 5.74; 95% confidence interval 1.74-20.2; P = .003 and odds ratio 1.04; 95% confidence interval 1.01-1.07; P = .007, respectively). T-wave oversensing was mostly observed during 0-6 AM, but no significant diurnal variations were observed in the incorrect QRS profiles. CONCLUSION The detection of diurnal variations through Holler monitoring in addition to conventional screening is expected to be useful for determining S-ICD eligibility.
引用
收藏
页码:913 / 920
页数:8
相关论文
共 50 条
  • [31] Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging
    Kahaly, Omar Ray
    Shafiei, Fereidoon
    Hardebeck, Charles
    Houmsse, Mahmoud
    TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (03): : 223 - 225
  • [32] Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
    Lambiase, Pier D.
    Theuns, Dominic A.
    Murgatroyd, Francis
    Barr, Craig
    Eckardt, Lars
    Neuzil, Petr
    Scholten, Marcoen
    Hood, Margaret
    Kuschyk, Jurgen
    Brisben, Amy J.
    Carter, Nathan
    Stivland, Timothy M.
    Knops, Reinoud
    Boersma, Lucas V. A.
    EUROPEAN HEART JOURNAL, 2022, 43 (21) : 2037 - 2050
  • [33] Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: A Brief Review of the Current Landscape
    Zheng, Henry C.
    Afshar, Hamid
    TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (06)
  • [34] Electromagnetic Interference from Electric Vehicles: Implications for Subcutaneous Implantable Cardioverter-Defibrillators
    Salam, Kamil
    Salih, Anmar
    Goswami, Tarun
    Wase, Abdul
    CIRCULATION, 2024, 150
  • [35] Predictors of pace-terminable rhythms in patients with subcutaneous implantable cardioverter-defibrillators
    Rao, Birju R.
    Jain, Vardhmaan
    Mekary, Wissam
    Ibrahim, Rand
    Bhatia, Neal K.
    El Chami, Mikhael
    Knops, Reinoud E.
    Lloyd, Michael S.
    HEART RHYTHM, 2024, 21 (11) : 2346 - 2347
  • [36] Quality of Life and Quality of Evidence for Subcutaneous Versus Transvenous Implantable Cardioverter-Defibrillators
    Caughron, Hope
    Dhruva, Sanket S.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (11):
  • [37] The Effect of Spironolactone on Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators
    Zarraga, Ignatius Gerardo E.
    Dougherty, Cynthia M.
    MacMurdy, Karen S.
    Raitt, Merritt H.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04): : 739 - 747
  • [38] SAFETY AND EFFICACY OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS LEAD REMOVAL: A SINGLE CENTER EXPERIENCE
    Pittorru, Raimondo
    Dall'aglio, Pietro Bernardo
    Falzone, Pasquale Valerio
    Lazzari, Enrico Giacomin
    De, Manuel
    Iliceto, Sabino
    Migliore, Federico
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [39] INVESTIGATING THE UTILITY OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IN THE ADULT CONGENITAL HEART DISEASE POPULATION
    Garside, H.
    de Bono, J.
    Hudsmith, L.
    Leyva-Leon, F.
    HEART, 2018, 104 : A1 - A2
  • [40] Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter-defibrillators
    Ho, AT
    Pai, S
    Timothy, P
    Pai, RG
    CIRCULATION, 2002, 106 (19) : 408 - 408